DynaDrug

Indication Heterozygous and Homozygous familial hypercholesterolemia, Prevention of atherosclerotic cardiovascular disease Dosage Dose is individualised according to baseline LDL-C levels, the goal of therapy, and patient response. As an adjunct to other lipid-lowering treatments...